About W. Middlekauff
Form D filings for Castle Creek Biosciences from 2021 to 2022 list W. Middlekauff as secretary.
W. Middlekauff first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name W. Middlekauff in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people W. Middlekauff works with at each company, as listed on that company's latest Form D.
Castle Creek Biosciences, Inc. · Form D, May 2, 2022
MG
Mark Graf
Director
MG
Matthew Gantz
Executive officer and director
MS
Mary Spellman
Executive officer
JA
Jeffrey Aronin
Director
PM
Patrick Morris
Director
AG
Antonio Gracias
Director